Radioimmunotherapy of ovarian cancerCRIPPA, F.The International journal of biological markers. 1993, Vol 8, Num 3, pp 187-191, issn 0393-6155Article

PF-03446962, a fully-human monoclonal antibody against transforming growth-factor 3 (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trialNECCHI, A; GIANNATEMPO, P; MAFFEZZINI, M et al.Investigational new drugs. 2014, Vol 32, Num 3, pp 555-560, issn 0167-6997, 6 p.Article

Radiation dose to technicians per nuclear medicine procedure : comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucoseCHIESA, C; DE SANCTIS, V; CRIPPA, F et al.European journal of nuclear medicine. 1997, Vol 24, Num 11, pp 1380-1389, issn 0340-6997Article

Evaluation of ventricular function by echocardiography and radionuclide angiography in patients treated with mitoxantroneVILLANI, F; GALIMBERTI, M; CRIPPA, F et al.Drugs under experimental and clinical research. 1989, Vol 15, Num 10, pp 501-506, issn 0378-6501Article

New anthracycline analogs in advanced breast cancerBONFANTE, V; FERRARI, L; BRAMBILLA, C et al.European journal of cancer & clinical oncology. 1986, Vol 22, Num 11, pp 1379-1385, issn 0277-5379Article

Activity of sunitinib in extraskeletal myxoid chondrosarcomaSTACCHIOTTI, S; PANTALEO, M. A; CONCA, E et al.European journal of cancer (1990). 2014, Vol 50, Num 9, pp 1657-1664, issn 0959-8049, 8 p.Conference Paper

Response to imatinib plus sirolimus in advanced chordomaSTACCHIOTTI, S; MARRARI, A; CASALI, P. G et al.Annals of oncology. 2009, Vol 20, Num 11, pp 1886-1894, issn 0923-7534, 9 p.Article

Electrocatalytic potentialities of silver as a cathode for organic halide reductionsRONDININI, S. B; MUSSINI, P. R; CRIPPA, F et al.Electrochemistry communications. 2000, Vol 2, Num 7, pp 491-496, issn 1388-2481Article

Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancerCRIPPA, F; AGRESTI, R; LEUTNER, M et al.The Journal of nuclear medicine (1978). 1998, Vol 39, Num 1, pp 4-8, issn 0161-5505Article

Comparison of three different methods for radiolabelling human activated T lymphocytesBOTTI, C; NEGRI, D. R. M; MASSARON, S et al.European journal of nuclear medicine. 1997, Vol 24, Num 5, pp 497-504, issn 0340-6997Article

Nuclear medicine procedures in lung cancerCHITI, A; SCHREINER, F. A. G; CRIPPA, F et al.European journal of nuclear medicine. 1999, Vol 26, Num 5, pp 533-555, issn 0340-6997Article

Association between [¹⁸F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer : a preliminary observationCRIPPA, F; SEREGNI, E; BOMBARDIERI, E et al.European journal of nuclear medicine. 1998, Vol 25, Num 10, pp 1429-1434, issn 0340-6997Article

Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomographyCHITI, A; AGRESTI, R; MAFFIOLI, L. S et al.European journal of nuclear medicine. 1997, Vol 24, Num 2, pp 192-196, issn 0340-6997Article

Prone scintimammography in patients with non-palpable breast lesionsMAFFIOLI, L; AGRESTI, R; CHITI, A et al.Anticancer research. 1996, Vol 16, Num 3A, pp 1269-1274, issn 0250-7005, 5 p.Article

Evaluation of cardiac toxicity of idarubicin (4-demethoxydaunorubicin)VILLANI, F; GALIMBERTI, M; COMAZZI, R et al.European journal of cancer & clinical oncology. 1989, Vol 25, Num 1, pp 13-18, issn 0277-5379Article

Preliminary evaluation of myocardial toxicity of 4'-deoxydoxorubicin: experimental and clinical resultsVILLANI, F; COMAZZI, R; FAVALLI, L et al.Drugs under experimental and clinical research. 1985, Vol 11, Num 3, pp 223-231, issn 0378-6501Article

[N-Methyl-¹¹C]choline by on-column reaction: a study on [¹¹C]CH₃l incorporation and the residual amount of precursor in the productBOGNI, A; CRISPU, O; FUGAZZA, L et al.Journal of labelled compounds & radiopharmaceuticals. 2011, Vol 54, Num 3-4, pp 157-162, issn 0362-4803, 6 p.Article

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II studyLOCATI, L. D; BOSSI, P; LIBERATOSCIOLI, C et al.Oral oncology (1997). 2009, Vol 45, Num 7, pp 574-578, issn 1368-8375, 5 p.Article

Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosumCRIMELLA, C; ARNOLDI, A; TOSCANO, A et al.Journal of medical genetics. 2009, Vol 46, Num 5, pp 345-351, issn 0022-2593, 7 p.Article

TANCLICO: Tools for the analysis of inter-departmental clinical communicationsPINCIROLI, F; CRIPPA, F; COMBI, C et al.Methods of information in medicine. 2000, Vol 39, Num 1, pp 44-49, issn 0026-1270Article

Artificial nutrition in cancer patients : Which route, what composition?BOZZETTI, F; GAVAZZI, C; MARIANI, L et al.World journal of surgery. 1999, Vol 23, Num 6, pp 577-583, issn 0364-2313Conference Paper

Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of MilanSEREGNI, E; CRIPPA, F; BOTTI, C et al.The International journal of biological markers. 1993, Vol 8, Num 2, pp 124-129, issn 0393-6155Article

Preparazione delle miscelle per nutrizione parenterale totale e controlli di sterilitàGILARDONI, A. M; ABBATISTA, M. R; MELESI, M et al.Rivista italiana di nutrizione parenterale ed enterale. 1990, Vol 8, Num 3, pp 213-215, issn 0393-5582Article

Phase II study of doxorubicin versus epirubicin in advanced breast cancerBRAMBILLA, C; ROSSI, A; BONFANTE, V et al.Cancer treatment reports. 1986, Vol 70, Num 2, pp 261-266, issn 0361-5960Article